Skip to Main Content

Paper Details

Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: a pilot study.
bioRxiv
1
2023
Author NameAffiliation
David A LewisUniversity of Pittsburgh School of Medicine
Robert A SweetUniversity of Pittsburgh School of Medicine
  • 1 - 2

Datasets

Release 1.2